Namangan Region Secures US$50M Deal with Krsnaa Diagnostics

Tashkent, Uzbekistan (UzDaily.com) — The Namangan region and the leading Indian medical company, Krsnaa Diagnostics Ltd, have signed a Memorandum of Understanding (MoU) valued at US$50 million. The document outlines the implementation of investment projects in the region focusing on healthcare and technological cooperation.

Earlier, on 1 March, company representatives visited several medical facilities in the Namangan region to assess existing infrastructure. Today, a delegation led by Chairman Rajendra Mutha arrived in the region to continue negotiations.

Krsnaa Diagnostics possesses over 20 years of experience in pharmaceuticals and diagnostics, managing a network of centers and laboratories across more than 150 districts in India, totaling over 2,000 facilities. The company operates more than 150 CT scanners, over 100 MRI machines, and more than 1,800 X-ray centers.

The Khokim of the Namangan region, Shavkatjon Abdurazzakov, held a meeting with the delegation to discuss the prospects for cooperation and investment initiatives. During the talks, the parties agreed to implement projects between 2026 and 2028 aimed at developing medical infrastructure, as well as industrial and technological collaboration.